Get started
Author

BINGSUO MA

Observed names: Bing-Suo Ma, Bingsuo Ma
ORCID: 0000-0002-4595-0355
Observed ORCID: 0000-0002-4595-0355
OpenAlex ID: A5103223379
Exploring calcium channel blocker as a candidate drug for Pseudomonas aeruginosa through network pharmacology and experimental validation
2023 · Zijun Yan, Liangjing Xia, et al. · Chemical Biology & Drug Design · 8
PDF
Exosomes and Their Application as Drug Delivery System in Cancer Therapy
2024 · KUN YANG, BINGSUO MA, et al. · Acta Poloniae Pharmaceutica - Drug Research · 3
PDF
Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy
2024 · Bingsuo Ma, Kun Yang, et al. · Therapeutic Drug Monitoring · 3
Effective Platform for Enhancing the Bioavailability and Anti-Cancer Efficacy of Norcantharidin: Nanoemulsion Hybrid Lipid Carriers
2023 · Zi-Jun Yan, Xiao-Ping Wu, et al. · Journal of Biomedical Nanotechnology · 1
Works count: 4
Citation count: 15
H-index: 3
I10-index:
Year
Topic
Type